A histopathological study of the effects of 6-month versus 12-month interferon alpha-2b therapy in chronic hepatitis C.

[1]  O. Weiland,et al.  Histological outcome in patients with chronic hepatitis C given a 60-week interferon alfa-2b treatment course. , 2008, Liver.

[2]  D. Dhumeaux,et al.  Interferon alfa and gamma inhibit proliferation and collagen synthesis of human ito cells in culture , 1995, Hepatology.

[3]  P. Bedossa,et al.  Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .

[4]  A. Craxì,et al.  Interferon‐α for chronic hepatitis C: An analysis of pretreatment clinical predictors of response , 1994 .

[5]  P. Jouet,et al.  Comparative efficacy of interferon alfa in cirrhotic and noncirrhotic patients with non-A, non-B, C hepatitis. Le Groupe Français pour l'Etude du Traitement des Hépatites Chroniques NANB/C. , 1994, Gastroenterology.

[6]  A. Czaja,et al.  Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. , 1993, Gastroenterology.

[7]  X. Causse,et al.  Interferon‐α2b therapy reduces liver fibrosis in chronic non‐A, non‐B hepatitis: A quantitative histological evaluation , 1993, Hepatology.

[8]  P. Marcellin.  Post treatment histologic outcome in patients with chronic hepatitis C treated with recombinant alpha interferon , 1993 .

[9]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[10]  H. Tsukuma,et al.  Risk factors for hepatocellular carcinoma among patients with chronic liver disease. , 1993, The New England journal of medicine.

[11]  G. Davis,et al.  Significance of serum hepatitis C virus RNA levels in chronic hepatitis C , 1993, The Lancet.

[12]  E. Schiff,et al.  Pathological diagnosis of chronic hepatitis C: a multicenter comparative study with chronic hepatitis B. The Hepatitis Interventional Therapy Group. , 1993, Gastroenterology.

[13]  A. Pucci,et al.  Histologic changes in liver biopsy specimens produced by recombinant interferon alpha-2b therapy for chronic non-A,non-B viral hepatitis. A randomized controlled trial. , 1992, American journal of clinical pathology.

[14]  M. Alter,et al.  Hepatitis C virus antigen in hepatocytes: immunomorphologic detection and identification. , 1992, Gastroenterology.

[15]  F. Schaffner,et al.  The histological features of chronic hepatitis C and autoimmune chronic hepatitis: A comparative analysis , 1992, Hepatology.

[16]  S. Sherlock,et al.  The pathology of hepatitis C , 1992, Hepatology.

[17]  X. Causse,et al.  Comparison of 1 or 3 MU of interferon alfa-2b and placebo in patients with chronic non-A, non-B hepatitis. , 1991, Gastroenterology.

[18]  J. Prieto,et al.  Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. , 1991, The New England journal of medicine.

[19]  Eugene R. Schiff,et al.  Treatment of Chronic Hepatitis C with Recombinant Interferon Alfa , 1989 .

[20]  S. Banks,et al.  Recombinant interferon alfa therapy for chronic hepatitis C. A randomized, double-blind, placebo-controlled trial. , 1989, The New England journal of medicine.

[21]  Neil Kaplowitz,et al.  Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.

[22]  P. Marcellin,et al.  [Treatment of viral hepatitis C]. , 1994, Gastroenterologie clinique et biologique.

[23]  J. Prieto,et al.  Randomised trial of lymphoblastoid alpha-interferon in chronic hepatitis C. Effects on inflammation, fibrogenesis and viremia. , 1993, Journal of hepatology.

[24]  J. Métreau.  Results of long term interferon treatment in non A non B/C chronic active hepatitis , 1993 .

[25]  O. Weiland,et al.  Interferon alpha-2b treatment of chronic posttransfusion non-A, non-B/C hepatitis: long-term outcome and effect of increased interferon doses in non-responders. , 1991, Scandinavian journal of infectious diseases.